Výsledky vyhledávání

Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: translational approach to improve survival

Autor: G.J. Peters, J. de Winter, Hendrik J. Bonjer, E. M. V. de Cuba, Marianne Tijssen, Beatriz Carvalho, Gerrit A. Meijer, P. M. Delis-van Diemen, Oscar Krijgsman, I. H. J. T. de Hingh, Martin A. Rooimans, R. Kwakman, E. A. te Velde

Publikováno v: British Journal of Cancer
British Journal of Cancer, 112(5), 851-856. Nature Publishing Group
Kwakman, R, de Cuba, E M V, de Winter, J P, de Hingh, I H J T, Delis-van Diemen, P M, Tijssen, M, Rooimans, M A, Krijgsman, O, Carvalho, B, Peters, G J, Bonjer, H J, Meijer, G A & te Velde, E A 2015, ' Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: translational approach to improve survival ', British Journal of Cancer, vol. 112, no. 5, pp. 851-856 . https://doi.org/10.1038/bjc.2015.18

Background: Patients with peritoneal metastases (PMs) originating from colorectal carcinoma (CRC) are curatively treated by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C (MMC). We aim to improve pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d31df72080d26f92ba56c520f6e8171
https://doi.org/10.1038/bjc.2015.18

Zobrazit plný text záznamu

Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases

Autor: Hendrik J. Bonjer, Gerrit A. Meijer, R. Kwakman, E. A. te Velde, E. M. V. de Cuba, D.L. Knol

Publikováno v: Cancer Treatment Reviews. 39:321-327

Objective Assess the overall outcome in colorectal cancer (CRC) patients that present with a combination of peritoneal metastases (PM) and liver metastases (CRLM) after curative resection and hyperthermic intraperitoneal chemotherapy (HIPEC) in the c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f10a94f070e3b7be4a4a69ecbf74e56
https://doi.org/10.1016/j.ctrv.2012.11.003

Zobrazit plný text záznamu

Surviving critical illness: what is next?

Autor: D. McWilliams, Linda Denehy, Bronwen Connolly, Raoul H.H. Engelbert, Rik Gosselink, Friedel Nollet, M. van der Schaaf, Christina Jones, R. Kwakman, Michelle E. Kho, Susan Hanekom, Shane Patman, Mel E. Major, Dale M. Needham

Publikováno v: Critical Care, 20:354. BioMed Central
Critical Care
Europe PubMed Central
Critical care (London, England), 20(1). Springer Science + Business Media

Background The study objective was to obtain consensus on physical therapy (PT) in the rehabilitation of critical illness survivors after hospital discharge. Research questions were: what are PT goals, what are recommended measurement tools, and what

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1983b02823e4081baaaf73e57e5c189c
https://hdl.handle.net/20.500.11884/724f2638-219f-4987-ae22-5347c80fe6c9

Zobrazit plný text záznamu

Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases A Meta-analysis

Autor: Anne M. Schrama, Josefien P. van Olmen, Erienne M.V. de Cuba, R. Kwakman, Elisabeth A. te Velde, Geert Kazemier, René H. J. Otten, Elly S.M. de Lange-de Klerk

Publikováno v: Kwakman, R, Schrama, A M, van Olmen, J P, Otten, R H, de lange-de Klerk, E S, de Cuba, E M, Kazemier, G & Velde, E A T 2016, ' Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases A Meta-analysis ', Annals of Surgery, vol. 263, no. 6, pp. 1102-1111 . https://doi.org/10.1097/SLA.0000000000001593
Annals of Surgery, 263(6), 1102-1111. Lippincott Williams and Wilkins

To improve patient selection for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) by evaluating various preoperatively assessable clinicopathological parameters as markers for survival after CRS and HIPEC.Peritoneal m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02cc27ae427f8931f9436f9ee31ea158
https://research.vumc.nl/en/publications/1a12a9d9-f01a-4a8a-a673-f2906f2b9756

Zobrazit plný text záznamu

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Autor: I. H. J. T. de Hingh, R. Kwakman, E. M. V. de Cuba, Wilhelmus J. H. J. Meijerink, Nina R. Sluiter, P. M. Delis-van Diemen, Veerle M.H. Coupé, E. A. te Velde, Jeroen A.M. Beliën, Gerrit A. Meijer

Publikováno v: Clinical & Experimental Metastasis, 33, 297-307
Clinical & Experimental Metastasis
Clinical & experimental metastasis, 33(4), 297-307. Springer Netherlands
Clinical & Experimental Metastasis, 33, 4, pp. 297-307
Sluiter, N R, de Cuba, E M V, Kwakman, R, Meijerink, W J H J, Delis-van Diemen, P M, Coupe, V M H, Belien, J A M, Meijer, G A, de Hingh, I H J T & te Velde, E A 2016, ' Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ', Clinical & experimental metastasis, vol. 33, no. 4, pp. 297-307 . https://doi.org/10.1007/s10585-016-9779-9

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can increase survival of colorectal cancer (CRC) patients with peritoneal metastases (PM). This treatment is associated with high morbidity and mortality rates. Therefo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3387a22657bb7f7d7129864614f154f
http://hdl.handle.net/2066/171929

Zobrazit plný text záznamu

Autor: I. H. J. T. de Hingh, Veerle M.H. Coupé, Jeroen A.M. Beliën, Wilhelmus J. H. J. Meijerink, Hendrik J. Bonjer, Nina R. Sluiter, P. M. Delis-van Diemen, E. M. V. de Cuba, R. Kwakman, Victor J. Verwaal, E. A. te Velde, Gerrit A. Meijer

Publikováno v: Annals of Surgical Oncology, 23, 5, pp. 1601-8
Annals of Surgical Oncology
Annals of Surgical Oncology, 23(5), 1601-1608. Springer New York
de Cuba, E M V, de Hingh, I H J T, Sluiter, N R, Kwakman, R, Coupe, V M H, Belien, J A M, Verwaal, V J, Meijerink, W J H J, Delis-van Diemen, P M, Bonjer, H J, Meijer, G A & te Velde, E A 2016, ' Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer ', Annals of Surgical Oncology, vol. 23, no. 5, pp. 1601-1608 . https://doi.org/10.1245/s10434-015-5023-0
Annals of Surgical Oncology, 23, 1601-8
de Cuba, E M V, de Hingh, I H J T, Sluiter, N R, Kwakman, R, Coupé, V M H, Beliën, J A M, Verwaal, V J, Meijerink, W J H J, Delis-van Diemen, P M, Bonjer, H J, Meijer, G A & Te Velde, E A 2016, ' Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer ', Annals of Surgical Oncology, vol. 23, no. 5, pp. 1601-8 . https://doi.org/10.1245/s10434-015-5023-0

Background Patients presenting with peritoneal metastases (PM) of colorectal cancer (CRC) can be curatively treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Angiogenesis is under control of multiple mole

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505c99d395e916b0429e88cecac5f022
https://hdl.handle.net/2066/171382

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání